5,000
Participants
Start Date
October 31, 2000
Primary Completion Date
June 30, 2004
Study Completion Date
June 30, 2004
undecavalent pneumococcal-protein D conjugate vaccine
GSK Investigational Site, Brno
GSK Investigational Site, České Budějovice
GSK Investigational Site, Děčín
GSK Investigational Site, Fryštát
GSK Investigational Site, Frýdek-Místek
GSK Investigational Site, Havlíčkův Brod
GSK Investigational Site, Hlinsko
GSK Investigational Site, Jičín
GSK Investigational Site, Jindřichův Hradec
GSK Investigational Site, Litoměřice
GSK Investigational Site, Náchod
GSK Investigational Site, Ostrava
GSK Investigational Site, Pardubice
GSK Investigational Site, Prague
GSK Investigational Site, Prague
GSK Investigational Site, Prague
GSK Investigational Site, Prague
GSK Investigational Site, Prague
GSK Investigational Site, Prague
GSK Investigational Site, Ústí nad Labem
GSK Investigational Site, Ústí nad Labem
GSK Investigational Site, Znojmo
GSK Investigational Site, Dolný Kubín
GSK Investigational Site, Dubnica nad Váhom
GSK Investigational Site, Košťany nad Turcom
GSK Investigational Site, Liptovský Hrádok
GSK Investigational Site, Liptovský Mikuláš
GSK Investigational Site, Martin
GSK Investigational Site, Námestovo
GSK Investigational Site, Nitra
GSK Investigational Site, Nová Dubnica
GSK Investigational Site, Nové Mesto nad Váhom
GSK Investigational Site, Nové Zámky
GSK Investigational Site, Považská Bystrica
GSK Investigational Site, Púchov
GSK Investigational Site, Ružomberok
GSK Investigational Site, Sučany
GSK Investigational Site, Štúrovo
GSK Investigational Site, Šurany
GSK Investigational Site, Trenčín
GSK Investigational Site, Zlaté Moravce
Lead Sponsor
GlaxoSmithKline
INDUSTRY